Form 13-F position report

MEDPACE HLDGS INC

Reported by GW&K Investment Management LLC

MEDP CUSIP 58506Q109 Manager CIK 0001082917

Reported 163,875 shares, down 8,821 (5.1%) from the prior quarter.

Reported value 11.8%; share count -5.1% vs. the prior quarter.

Reduced
% of reported 13F value 0.87% This manager · Q3 2026
Shares 163,875 Quarter-end amount reported
Reported value $102,290,000 Fair value at quarter end
Consecutive quarters held 24 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 72903000
2022-03-31 54009000
2022-06-30 52148000
2022-09-30 40054000
2022-12-31 53702000
2023-03-31 47659000
2023-06-30 60227000
2023-09-30 56369000
2023-12-31 67549000
2024-03-31 69805000
2024-06-30 70643000
2024-09-30 47426000
2024-12-31 91516000
2025-03-31 82497000
2025-06-30 81513000
2025-09-30 101941000
2025-12-31 87733000
2026-03-31 87768000
2026-06-30 91461000
2026-09-30 102290000

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for MEDPACE HLDGS INC held by GW&K Investment Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 163,875 -8,821 (-5.1%) 0.87% $102,290,000 2026-11-10
Q2 2026 Reduced 172,696 -10,076 (-5.5%) 0.71% $91,461,000 2026-08-12
Q1 2026 Added 182,772 +26,574 (17.0%) 0.77% $87,768,000 2026-05-13
Q4 2025 Reduced 156,198 -42,063 (-21.2%) 0.76% $87,733,000 2026-02-11
Q3 2025 Reduced 198,261 -61,442 (-23.7%) 0.9% $101,941,000 2025-11-12
Q2 2025 Reduced 259,703 -11,053 (-4.1%) 0.73% $81,513,000 2025-08-11
Q1 2025 Reduced 270,756 -4,704 (-1.7%) 0.76% $82,497,000 2025-05-05
Q4 2024 Added 275,460 +133,379 (93.9%) 0.78% $91,516,000 2025-02-05
Q3 2024 Reduced 142,081 -29,445 (-17.2%) 0.41% $47,426,000 2024-11-07
Q2 2024 Reduced 171,526 -1,195 (-0.7%) 0.65% $70,643,000 2024-08-12
Q1 2024 Reduced 172,721 -47,647 (-21.6%) 0.62% $69,805,000 2024-05-08
Q4 2023 Reduced 220,368 -12,439 (-5.3%) 0.63% $67,549,000 2024-02-09
Q3 2023 Reduced 232,807 -17,960 (-7.2%) 0.57% $56,369,000 2023-11-09
Q2 2023 Reduced 250,767 -2,669 (-1.1%) 0.57% $60,227,000 2023-08-09
Q1 2023 Added 253,436 +616 (0.2%) 0.46% $47,659,000 2023-05-09
Q4 2022 Reduced 252,820 -2,022 (-0.8%) 0.54% $53,702,000 2023-02-10
Q3 2022 Reduced 254,842 -93,578 (-26.9%) 0.44% $40,054,000 2022-11-09
Q2 2022 Added 348,420 +18,274 (5.5%) 0.56% $52,148,000 2022-08-09
Q1 2022 Reduced 330,146 -4,823 (-1.4%) 0.48% $54,009,000 2022-05-09
Q4 2021 Reduced 334,969 -58,654 (-14.9%) 0.61% $72,903,000 2022-02-11
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

818 managers reported MEDPACE HLDGS INC for Q3 2026.

Managers reporting MEDPACE HLDGS INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 2,562,937 +64,689 0.02% $1,599,734,025 9 qtrs
AQR CAPITAL MANAGEMENT LLC Added 1,396,654 +117,719 0.26% $863,222,956 35 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 1,136,249 -933,428 0.07% $709,225,000 33 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Reduced 1,085,294 -48,063 0.03% $677,418,809 3 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Reduced 1,005,976 -20,844 0.01% $627,910,100 3 qtrs
STATE STREET CORPORATION Added 714,316 +3,421 0.01% $445,861,761 41 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 712,423 +1,958 0.02% $444,747,242 41 qtrs
Invesco Ltd Reduced 501,572 -77,669 0.02% $313,071,212 41 qtrs
ARROWSTREET CAPITAL LIMITED PARTNERSHIP Added 499,798 +70,786 0.13% $311,963,916 29 qtrs
WASATCH ADVISORS INC Reduced 465,944 -170,651 2.16% $290,832,926 32 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 10, 2026
Filing type
13F-HR
Position type
COMMON

Voting authority reported

Sole
153,528
Shared
10,291
None
56

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.